Market Place
Sourcing Support
4D Path Joins Phase II Trial to Advance Predictive Diagnostics
22 Jan 2026 //
GLOBENEWSWIRE
Study Finds HIV Can Evolve To Resist Lenacapavir—At A Cost
07 Jan 2026 //
FIERCE BIOTECH
Study: One-Third of Trial Data May Be Unnecessary
19 Sep 2025 //
FIERCE BIOTECH
Tomas Cihlar of Gilead Sciences on TIME`s 100
20 May 2025 //
ACCESSWIRE
Earth Day Focus for Gilead Sciences - Every Action Has an Impact
08 May 2025 //
ACCESSWIRE
Gilead Backs HIV Prevention Summit in Atlanta
22 Apr 2025 //
ACCESSWIRE
Gilead Sciences - Women`s History Month Celebrated With Its Team
14 Mar 2025 //
ACCESSWIRE
Energize Supports Global Healthcare Firms with Multi-buyer PPA
06 Feb 2025 //
BUSINESSWIRE
AI-powered Terray is teaming up with Gilead in a fresh R&D pact
17 Dec 2024 //
FIERCE BIOTECH
Helping End HIV - Gilead Sciences
12 Sep 2024 //
ACCESSWIRE
Gilead inks $35M collab with AI drug discovery outfit Genesis
10 Sep 2024 //
FIERCE BIOTECH
Gilead pays J&J $320M to exit licensing deal for seladelpar
09 Aug 2024 //
FIERCE BIOTECH
Kite Presents Yescarta Data For Earlier Treatment Lines
14 Jun 2024 //
BUSINESSWIRE
Gilead Sciences: Preserving Fertility in the Face of a Cancer Diagnosis
05 Jun 2024 //
ACCESSWIRE
As Covid program advances, Enanta`s new CMO says it`s not `limited to antivirals
12 Aug 2022 //
ENDPTS
GSK`s ViiV, Pfizer and Roche score high with patient groups
27 Apr 2022 //
FIERCEPHARMA
Could this low-cost leprosy drug be repurposed for COVID-19?
17 Mar 2021 //
FIERCEBIOTECH
A payoff for taxpayers? CDC may have claims on remdesivir patents by Gilead
07 Dec 2020 //
STATNEWS
Why the approval of remdesivir to treat Covid-19 obscures bigger failures
23 Oct 2020 //
STATNEWS
Tackling multiple sclerosis with a plant sugar
16 Oct 2020 //
FIERCE BIOTECH
Analysis: Sales of first big COVID-19 drug, remdesivir, may disappoint
15 Oct 2020 //
REUTERS
Late-stage study of COVID-19 convalescent-plasma treatment remdesivir starts
09 Oct 2020 //
REUTERS
Cats point the way to potential COVID-19 remedies
31 Aug 2020 //
FIERCEBIOTECH
Teon Therapeutics Appoints Biotech Veteran Louis Lange as Independent
24 Aug 2020 //
PRNEWSWIRE
It still takes 2 to Tango as Gilead triples targets in I-O deal
17 Aug 2020 //
FIERCEBIOTECH
Daniel O’Day snatches another I/O company, buying half of a pioneering drug
23 Jun 2020 //
ENDPTS
Why Drug Companies May Resist Milking Covid-19 Treatments
10 Jun 2020 //
WSJ
Researchers define exactly what they saw in the first positive remdesivir study
23 May 2020 //
ENDPTS
More companies in talks for Remdesivir licence
15 May 2020 //
ECONOMICTIMES
Affordable access to Covid-19 drugs: Are voluntary patent licences here to stay?
15 May 2020 //
ECONOMICTIMES
Health groups ask India to rescind Gilead`s patents for COVID-19 drug remdesivir
14 May 2020 //
REUTERS
Dozens of coronavirus drugs are in development — what happens next?
14 May 2020 //
NATURE
Health groups ask India to rescind Gilead`s patents for COVID-19 drug remdesivir
13 May 2020 //
ECONOMIC TIMES
A closer look at the race to develop antibody drugs for COVID-19
12 May 2020 //
BIOPHARMADIVE
Ebola drug shown to work against coronavirus `could cost up to $4,500 treatment`
07 May 2020 //
MIRROR
COVID-19 tracker: Drug pricing watchdog weighs in on remdesivir
04 May 2020 //
FIERCE PHARMA
The drugs and treatments that could stop Covid-19
27 Apr 2020 //
POLITICO
A slice of half-baked remdesivir data takes a dark turn
24 Apr 2020 //
ENDPTS
COVID-19: New data back up remdesivir as more candidates emerge
20 Apr 2020 //
FIERCE BIOTECH
Antiviral remdesivir prevents disease progression in monkeys with COVID-19
17 Apr 2020 //
NIH
Researchers Target NAFLD, NASH Using Lab-on-a-Chip Technology
30 Aug 2019 //
BIOSPACE
AIDS activists skewer CDC for conflicting stance collecting HIV drug royalties
11 Apr 2019 //
STATNEWS
Yescarta rejected among other SMC decisions
13 Feb 2019 //
PHARMA TIMES
GSK looks to oncology for growth as Advair generic hits
06 Feb 2019 //
FIERCE PHARMA
Gilead takes an $820M hit after axing a Kite CAR-T
04 Feb 2019 //
ENDPTS
Agenus` blockchain tech for new ‘digital security’ for PD-1, but will it work?
29 Jan 2019 //
ENDPTS
Yale Researchers Discover Protein in the Immune System Can Help Suppress HIV
22 Jan 2019 //
BIOSPACE
Gilead stuffs another NASH drug discovery program into a growing portfolio
04 Jan 2019 //
ENDPTS
Gilead and Agenus sign cancer drug development deal
22 Dec 2018 //
PHARMACEUTICAL-TECH
Xenotransplantation firm eGenesis hires new R&D head
07 Dec 2018 //
FIERCE BIOTECH
Political Battle Over Fetal Tissue Could Force Closure of Research Center
06 Dec 2018 //
BIOSPACE
#ASH18: Gilead posts impressive survival rates for Yescarta
03 Dec 2018 //
ENDPTS
Off-the-shelf cell therapy for cancer? Fate Therapeutics to make its case at ASH
30 Nov 2018 //
FIERCE BIOTECH
Hep B company Antios nabs $25M Series A
28 Nov 2018 //
ENDPTS
ASH 2018:A Guide to the Latest for Blood-Borne Cancers and More
26 Nov 2018 //
XCONOMY
It Takes Two: Gilead and Tango Partner on Immuno-Oncology
31 Oct 2018 //
BIOSPACE
Gilead`s Biktarvy on par with DTG+FTC/TAF in late-stage HIV study
31 Oct 2018 //
SEEKING ALPHA
Gilead Announces Results From Phase 3 Study of Biktarvy
30 Oct 2018 //
BUSINESSWIRE
Gilead`s HIV portfolio soars, but HCV sales falling?
27 Oct 2018 //
FIERCE PHARMA
Gilead, Aelix ally to trial HIV-suppressing combination
19 Oct 2018 //
FIERCE PHARMA
